On 11/10/2017 the prior information notice for the project ANTI-SUPERBUGS has been published in the European Tenders Electronic Daily. The ANTI–SUPERBUGS pre-commercial procurement aims to improve the quality of care processes in hospital and the reduction of both the costs and the collateral effects provoked by Multi-Drug Resistant Organisms (MDROs, otherwise known as Superbugs) and other Health Associated Infections (HAIs) pathogens, through the development and testing of prototypes of devices and ICT services that can:
- test non-invasively for the presence of MDROs and other pathogens, and
- provide continuous information and remote alerts to health professionals on environmental contamination by MDROs — and other pathogens — on high contact surfaces, applicable to existing healthcare environments.
More details are available here.
The Challenge Briet in a Nutshell New!